Figure 3

Overall survival (OS) and progression free survival according to clinical stage (CS). OS (A) at 5 year was 100% for CS I, 98% for CS II, 100% for CS III and 78% for CS IV. PFS (B) at 5 year was 100% for CS I, 98.5% for CS II, 100% for CS III and 81% for CS IV.